136 related articles for article (PubMed ID: 37162543)
1. Fasudil promotes polyploidization of megakaryoblasts in an acute megakaryocyte leukemia model.
He B; Wang C; Niu J; Wang F; Zhang Y; Gao Y; Yang Q
Naunyn Schmiedebergs Arch Pharmacol; 2023 Nov; 396(11):3101-3110. PubMed ID: 37162543
[TBL] [Abstract][Full Text] [Related]
2. Identification of regulators of polyploidization presents therapeutic targets for treatment of AMKL.
Wen Q; Goldenson B; Silver SJ; Schenone M; Dancik V; Huang Z; Wang LZ; Lewis TA; An WF; Li X; Bray MA; Thiollier C; Diebold L; Gilles L; Vokes MS; Moore CB; Bliss-Moreau M; Verplank L; Tolliday NJ; Mishra R; Vemula S; Shi J; Wei L; Kapur R; Lopez CK; Gerby B; Ballerini P; Pflumio F; Gilliland DG; Goldberg L; Birger Y; Izraeli S; Gamis AS; Smith FO; Woods WG; Taub J; Scherer CA; Bradner JE; Goh BC; Mercher T; Carpenter AE; Gould RJ; Clemons PA; Carr SA; Root DE; Schreiber SL; Stern AM; Crispino JD
Cell; 2012 Aug; 150(3):575-89. PubMed ID: 22863010
[TBL] [Abstract][Full Text] [Related]
3. Targeting cyclin-dependent kinases 4/6 inhibits survival of megakaryoblasts in acute megakaryoblastic leukaemia.
Qi K; Hu X; Yu X; Cheng H; Wang C; Wang S; Wang Y; Li Y; Cao J; Pan B; Wu Q; Qiao J; Zeng L; Li Z; Xu K; Fu C
Leuk Res; 2022 Sep; 120():106920. PubMed ID: 35872339
[TBL] [Abstract][Full Text] [Related]
4. BMP2K dysregulation promotes abnormal megakaryopoiesis in acute megakaryoblastic leukemia.
Wang M; Zhang T; Zhang X; Jiang Z; Peng M; Huang Z
Cell Biosci; 2020; 10():57. PubMed ID: 32322386
[TBL] [Abstract][Full Text] [Related]
5. Megakaryoblastic leukemia: a study on novel role of clinically significant long non-coding RNA signatures in megakaryocyte development during treatment with phorbol ester.
Dahariya S; Raghuwanshi S; Sangeeth A; Malleswarapu M; Kandi R; Gutti RK
Cancer Immunol Immunother; 2021 Dec; 70(12):3477-3488. PubMed ID: 33890137
[TBL] [Abstract][Full Text] [Related]
6. [Blocking PAK1 kinase activity promotes the differentiation of acute megakaryocytic leukemia cells and induces their apoptosis].
Wang SJ; Wang CQ; Hu XT; Yu XR; Fu CL
Zhonghua Xue Ye Xue Za Zhi; 2022 Jun; 43(6):499-505. PubMed ID: 35968594
[No Abstract] [Full Text] [Related]
7. Tetrandrine antagonizes acute megakaryoblastic leukaemia growth by forcing autophagy-mediated differentiation.
Liu T; Zhang Z; Yu C; Zeng C; Xu X; Wu G; Huang Z; Li W
Br J Pharmacol; 2017 Dec; 174(23):4308-4328. PubMed ID: 28901537
[TBL] [Abstract][Full Text] [Related]
8. Molecular pathways: induction of polyploidy as a novel differentiation therapy for leukemia.
Krause DS; Crispino JD
Clin Cancer Res; 2013 Nov; 19(22):6084-8. PubMed ID: 23963861
[TBL] [Abstract][Full Text] [Related]
9. Protective Effects of a Rho Kinase Inhibitor on Paraquat-Induced Acute Lung Injuries in Rats.
Zhang L; Li Q; Liu Z; Liu W; Zhao M
Inflammation; 2018 Dec; 41(6):2171-2183. PubMed ID: 30088170
[TBL] [Abstract][Full Text] [Related]
10. Fasudil or genetic depletion of ROCK1 or ROCK2 induces anxiety-like behaviors.
Greathouse KM; Henderson BW; Gentry EG; Herskowitz JH
Behav Brain Res; 2019 Nov; 373():112083. PubMed ID: 31302146
[TBL] [Abstract][Full Text] [Related]
11. [Megakaryocytic leukemia cell lines and megakaryocytic leukemia].
Ryo R; Yoshida A; Yamaguchi N
Rinsho Byori; 1990 May; 38(5):514-23. PubMed ID: 2381077
[TBL] [Abstract][Full Text] [Related]
12. Rho-kinase inhibitor, fasudil, suppresses glioblastoma cell line progression in vitro and in vivo.
Deng L; Li G; Li R; Liu Q; He Q; Zhang J
Cancer Biol Ther; 2010 Jun; 9(11):875-84. PubMed ID: 20364104
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of glutamate regulated calcium entry into leukemic megakaryoblasts reduces cell proliferation and supports differentiation.
Kamal T; Green TN; Morel-Kopp MC; Ward CM; McGregor AL; McGlashan SR; Bohlander SK; Browett PJ; Teague L; During MJ; Skerry TM; Josefsson EC; Kalev-Zylinska ML
Cell Signal; 2015 Sep; 27(9):1860-72. PubMed ID: 25982509
[TBL] [Abstract][Full Text] [Related]
14. Exposure to the ROCK inhibitor fasudil promotes gliogenesis of neural stem cells in vitro.
Nizamudeen ZA; Chakrabarti L; Sottile V
Stem Cell Res; 2018 Apr; 28():75-86. PubMed ID: 29448133
[TBL] [Abstract][Full Text] [Related]
15. Alleviation of the doxorubicin-induced nephrotoxicity by fasudil in vivo and in vitro.
Xiang C; Yan Y; Zhang D
J Pharmacol Sci; 2021 Jan; 145(1):6-15. PubMed ID: 33357780
[TBL] [Abstract][Full Text] [Related]
16. JAK2T875N is a novel activating mutation that results in myeloproliferative disease with features of megakaryoblastic leukemia in a murine bone marrow transplantation model.
Mercher T; Wernig G; Moore SA; Levine RL; Gu TL; Fröhling S; Cullen D; Polakiewicz RD; Bernard OA; Boggon TJ; Lee BH; Gilliland DG
Blood; 2006 Oct; 108(8):2770-9. PubMed ID: 16804112
[TBL] [Abstract][Full Text] [Related]
17. Fasudil, a Rho kinase inhibitor, drives mobilization of adult neural stem cells after hypoxia/reoxygenation injury in mice.
Ding J; Li QY; Yu JZ; Wang X; Sun CH; Lu CZ; Xiao BG
Mol Cell Neurosci; 2010 Feb; 43(2):201-8. PubMed ID: 19913617
[TBL] [Abstract][Full Text] [Related]
18. Fasudil protects hippocampal neurons against hypoxia-reoxygenation injury by suppressing microglial inflammatory responses in mice.
Ding J; Li QY; Wang X; Sun CH; Lu CZ; Xiao BG
J Neurochem; 2010 Sep; 114(6):1619-29. PubMed ID: 20882700
[TBL] [Abstract][Full Text] [Related]
19. FSD-C10: A more promising novel ROCK inhibitor than Fasudil for treatment of CNS autoimmunity.
Xin YL; Yu JZ; Yang XW; Liu CY; Li YH; Feng L; Chai Z; Yang WF; Wang Q; Jiang WJ; Zhang GX; Xiao BG; Ma CG
Biosci Rep; 2015 Jul; 35(5):. PubMed ID: 26223433
[TBL] [Abstract][Full Text] [Related]
20. [SP600125-induced polyploidization of megakaryocytic leukemia cell lines by ribosomal protein S6 kinase 1 depends on the degree of cell differentiation].
Wang L; Yang J; Li C; Xing S; Yu Y; Liu S; Zhao S; Ma D
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Oct; 32(10):1336-1341. PubMed ID: 27667458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
